PNGA — Pangea Wellness Income Statement
0.000.00%
- CA$15.77m
- CA$13.95m
- CA$0.01m
- 50
- 10
- 63
- 35
Annual income statement for Pangea Wellness, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
C2021 October 31st | R2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.069 | 0.581 | 0.286 | 0.012 |
| Cost of Revenue | ||||
| Gross Profit | -0.007 | 0.041 | -0.033 | 0.007 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 0.242 | 1.7 | 1.94 | 1.04 |
| Operating Profit | -0.173 | -1.12 | -1.65 | -1.03 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.173 | -1.13 | -1.66 | -1.03 |
| Net Income After Taxes | -0.173 | -1.13 | -1.66 | -1.03 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.173 | -1.13 | -1.66 | -1.03 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.173 | -1.13 | -1.66 | -1.03 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.038 | -0.198 | -0.291 | -0.143 |
| Dividends per Share |